World Health Organization Advice to Protect Against Long Covid
The World Health Organization has joined the US CDC and HHS in providing new guidance on the ongoing…
Recovery and symptom trajectories up to two years after SARS-COV-2 infection: population based, longitudinal cohort study
“Up to 18% of individuals who were not vaccinated before infection had post-covid-19 condition up to two years…
First Long COVID Newsletter!
The first issue of the Long COVID newsletter is out now! Do not miss this opportunity to learn more about…
Immunologist Akiko Iwasaki: ‘We are not done with Covid, not even close’
The Yale professor and Long COVID expert gave a really interesting interview to The Guardian on why the virus is causing ongoing illness for…
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
“In this analysis of data from 9764 participants in the RECOVER adult cohort, a prospective longitudinal cohort study,…
Myricetin possesses the potency against SARS-CoV-2 infection through blocking viral-entry facilitators and suppressing inflammation in rats and mice
This recent study showed that myricetin (3,5,7-trihydroxy-2-(3,4,5-tri hydroxyphenyl)-4-benzopyrone), a common flavonol extracted from many natural plants and Chinese…
SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase
A study by the University of Helsinki, carried out in the frame of the Long COVID project, has discovered the main…
Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations
Self-reported symptom studies rapidly increased understanding of SARS-CoV-2 during the COVID-19 pandemic and enabled monitoring of long-term effects…